Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Swain

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Pharmacoeconomics|March 12, 2003
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis CJens Rasenack, Stefan Zeuzem, S Victor Feinman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 29, 2021
Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, CanadaAbdel Aziz Shaheen, Kristine Kong, Christopher Ma, et al.
Frontiers in Immunology|April 20, 2019
The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center StudyGary L Norman, Anna Reig, Odette Viñas, et al.
Brain, Behavior, and Immunity|March 8, 2022
Colitis-associated microbiota drives changes in behaviour in male mice in the absence of inflammationFernando A Vicentini, Jake C Szamosi, Laura Rossi, et al.
Gastroenterology|July 20, 2010
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirinMark G Swain, Ming-Yang Lai, Mitchell L Shiffman, et al.
Journal of Hepatology|September 5, 2020
Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinomaJacob H Charette, Kelly W Burak, Carla S Coffin, et al.
Plos One|April 24, 2014
Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver diseaseJack X Q Pang, Scott Zimmer, Sophia Niu, et al.
CMAJ Open|January 7, 2018
Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patientsAlex I Aspinall, Abdel A Shaheen, Golasa S Kochaksaraei, et al.
Hepatology Communications|September 14, 2020
Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary CholangitisSurain B Roberts, Marwa Ismail, Gowthami Kanagalingam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 27, 2021
Association Between Endoscopist Specialty and Colonoscopy Quality: A Systematic Review and Meta-analysisMatthew Mazurek, Alistair Murray, Steven J Heitman, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Pharmacoeconomics|March 12, 2003
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis CJens Rasenack, Stefan Zeuzem, S Victor Feinman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 29, 2021
Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, CanadaAbdel Aziz Shaheen, Kristine Kong, Christopher Ma, et al.
Frontiers in Immunology|April 20, 2019
The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center StudyGary L Norman, Anna Reig, Odette Viñas, et al.
Brain, Behavior, and Immunity|March 8, 2022
Colitis-associated microbiota drives changes in behaviour in male mice in the absence of inflammationFernando A Vicentini, Jake C Szamosi, Laura Rossi, et al.
Gastroenterology|July 20, 2010
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirinMark G Swain, Ming-Yang Lai, Mitchell L Shiffman, et al.
Journal of Hepatology|September 5, 2020
Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinomaJacob H Charette, Kelly W Burak, Carla S Coffin, et al.
Plos One|April 24, 2014
Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver diseaseJack X Q Pang, Scott Zimmer, Sophia Niu, et al.
CMAJ Open|January 7, 2018
Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patientsAlex I Aspinall, Abdel A Shaheen, Golasa S Kochaksaraei, et al.
Hepatology Communications|September 14, 2020
Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary CholangitisSurain B Roberts, Marwa Ismail, Gowthami Kanagalingam, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 27, 2021
Association Between Endoscopist Specialty and Colonoscopy Quality: A Systematic Review and Meta-analysisMatthew Mazurek, Alistair Murray, Steven J Heitman, et al.
Pageof 14